Companies › COGT
COGENT BIOSCIENCES INC (COGT)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001622229 · EDGAR filings · Updated 2026-07-27
COGENT BIOSCIENCES INC (COGT) has reported institutional ownership of 109.0%, with 305 institutional managers holding positions valued at $7.17B per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (1)
- 2026-07-27 — SCHEDULE 13G/A filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-06 — Insider transaction reported (Form 4)
- 2026-06-11 — Insider transaction reported (Form 4)
- 2026-06-11 — Insider transaction reported (Form 4)
- 2026-06-11 — Insider transaction reported (Form 4)
- 2026-06-11 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, COGENT BIOSCIENCES INC has 305 institutional holders and institutional ownership of 109.0%.
Insider activity
Insiders reported 26 transactions (1 buys, 6 sells) across 7 reporting insiders, with a net reported value of −$357.2M.
Data flags from SEC filings
Related companies
REPLIGEN CORP COM (RGEN) · ARROWHEAD PHARMACEUTICALS IN (ARWR) · KRYSTAL BIOTECH INC (KRYS) · APOGEE THERAPEUTICS INC (APGE) · SCHOLAR ROCK HLDG CORP (SRRK) · PTC THERAPEUTICS INC (PTCT)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.